Search results
Klaviyo, Inc. (NYSE:KVYO) Director Jennifer Ceran Sells 13,000 Shares
ETF DAILY NEWS· 2 days agoKlaviyo, Inc. (NYSE:KVYO – Get Free Report) Director Jennifer Ceran sold 13,000 shares of the stock...
Klaviyo Inc [KVYO] Records 50-Day SMA of $24.09 – Knox Daily
Knox Daily· 2 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Klaviyo Inc shares valued at $320,450 were sold by Ceran Jennifer on ...
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 2 days agoNeedham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as of...
Is It Time to Buy the Dip in Shopify Stock?
Motley Fool via Yahoo Finance· 6 days agoAt the end of March 2024, the value of these holdings was $1.89 billion, down from $2.23 billion three months prior, because all three stocks performed...
Retail Tech: Kohl’s Teams with Instacart for Same-Day Delivery, URBN Taps Stripe for Payments
Sourcing Journal via Yahoo News· 4 days agoWith this capital, Swap will launch Swap Global, allowing the company to unlock new markets through...
Cloud Startup Grafana Labs In Talks To Raise New Funding At $6 Billion Valuation
Forbes· 2 days agoThe funding round, which sources say will be led by existing investors Lightspeed and GIC, is...
The 49-Year Unicorn Backlog
Crunchbase· 6 days agoIf the current sluggish pace of IPOs and acquisitions continues, it would take more than 49 years for every U.S. unicorn to generate an exit. Over the past 12 months, just 15 private, venture-backed ...
OneStock Announces $72 Million Investment to Help Brands Unlock Their Full Omnichannel Potential
Benzinga· 5 days agoOneStock SAS, a leading provider of Order Management Systems (OMS), today announced a $72 million investment from global growth equity investor Summit Partners. OneStock was founded in 2015 ...
The Premier Go-to-Market VC for B2B Founders, Stage 2 Capital Kicks Off the 2024 Catalyst
NBC 17 Raleigh· 4 days agoStage 2 Capital today announced it is accepting applications for the 2024 Catalyst, the go-to-market (GTM) acceleration program for early stage B2B founders. Backed by 300+ GTM executives from ...
Boston’s Rapport Therapeutics lays out plans for IPO - Boston Business Journal
The Business Journals· 5 days agoJust a year after emerging from stealth, a Boston startup working on precision medicines for brain...
